Smsbiotech Inc. has gained clearance in Australia to begin a phase I trial of its small mobile stem (SMS) cell therapy for chronic obstructive pulmonary disease (COPD).
Dear Dr. Roach: My wife has COPD. She is not coping very well. Her doctors are treating her with the standard medications. She has heard about an experimental treatment where they take her stem cells ...
Andrew Cassy had spent his working life in a telecommunications research department until a diagnosis of Parkinson’s disease in 2010 pushed him into early retirement. Curious about his illness, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback